Navigation Links
KJT Group Hires Director of Health Outcomes
Date:7/9/2013

HONEOYE FALLS, N.Y., July 8, 2013 /PRNewswire/ -- KJT Group, Inc. is pleased to announce the hiring of Arun Changolkar, PhD, MBA as the Director of Health Outcomes Research to its expanding life sciences research and consulting organization.

Dr. Changolkar, of Philadelphia, brings extensive academic and professional experience in health economics and outcomes research. His experience includes leadership roles in the pharmaceutical and clinical research industries. With expertise in epidemiology and statistics his project experience spans both U.S. and global healthcare in oncology, vaccines, and autoimmune disease. 

He joins KJT Group after serving in various industry positions including Director of Global Health Outcomes at Stiefel and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country specific successful reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies to generate clinical evidence.  He also participated in and contributed to strategic pricing, global value dossier synthesis, and core value development for various pharmaceutical products. Changolkar's accomplishments include numerous abstracts in international and national scientific meetings and 11 publications in scientific journals. 

"Arun brings a very nice mix of skills and experience to KJT Group's growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face," said Kenneth Tomaszewski, PhD, MS, Founder and CEO of KJT Group.

Following the completion of his PhD, Changolkar received post-doctoral training as an Anticancer Drug Discovery Researcher at Harvard Medical School and an Epigenetics Researcher at the University of Pennsylvania in Philadelphia.

As the Director of Health Outcomes Research at KJT Group, Changolkar will work closely with KJT Group researchers and oversee the design and conduct of KJT Group's health economics and outcomes research studies.

About KJT Group: KJT Group (www.kjtgroup.com) is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands. KJT Group is a member of the National Council on Public Polls (NCPP), Council of American Survey Research Organizations (CASRO) and the European Society Opinion and Marketing Research (ESOMAR).


'/>"/>
SOURCE KJT Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
2. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
3. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
4. Cellular Biomedicine Group Announces Appointment of Corporate Controller
5. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
6. The JTB Law Group Continues to Innovate with its New Video Information Series and Vivid Legal Cartoons
7. The Hemostemix Group of Companies Provides Corporate Strategy Update
8. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
9. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
10. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
11. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... 04, 2016 , ... Many of the engineers at FireflySci, Inc. have been ... them apart from other cuvette manufacturers is their supercharged customer service and their extensive ... of this steady flow of inside information, they have recently revamped their manufacturing techniques ...
(Date:2/3/2016)... Denmark , Feb. 3, 2016 Ascendis ... biotechnology company that applies its innovative TransCon technology to ... present at an upcoming investor conference.Event:2016 Leerink Partners Global ... NY Date:  , Wednesday, February 10, 2016 Time:  ... www.ascendispharma.com . --> An audio webcast ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... validating a series of potential targets (epitopes) specific to misfolded, propagating strains of ... to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the ...
(Date:2/3/2016)... PALO ALTO, Calif. , Feb. 3, 2016 /PRNewswire/ ... the sale of AlphaImpactRx , a leading provider ... consumer health companies to IMS Health , a ... industry. AlphaImpactRx,s complementary offerings, capabilities and technologies will be ... the company,s growing global primary market research capabilities. ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of that Rising Market Are you interested ... analysis forecasts revenues for checkpoint inhibitors. Visiongain,s report ... market, submarket, product and national level. Avoid ... discover what progress, opportunities and revenues those emerging ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
Breaking Biology News(10 mins):